AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ: AVBP · HEALTHCARE · BIOTECHNOLOGY
$31.09
+3.46% today
Updated 2026-04-30
Market cap
$1.34B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$16 – $32
Volume
0.5M
ArriVent BioPharma, Inc. Common Stock (AVBP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-12.59M | $-43.63M | $-55.84M | $-70.21M | $-160.59M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $66667.00 | $424000.00 | $895000.00 | $3.21M | $12.52M |
| Free cash flow | $-12.59M | $-43.63M | $-55.84M | $-70.21M | $-160.59M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |